FAKTOR-OPTIONSSCHEIN - UCB Share Price

DE000SR8V4E1

Delayed Deutsche Boerse AG 19:01:27 13/05/2024 BST
0.5 ^EUR	+4.17%

Current month	+2.13%
1 month	-23.81%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB - Acquisition of own shares	04:24pm	AQ
UCB : Acquisition of own shares	05-10	PU
UCB presents final open-label extension F data at International Child Neurology Congress Annual Meeting	05-09	AQ
UCB : presents final open-label extension F®▼(fenfluramine) data at International Child Neurology Congress (ICNC) Annual Meeting	05-08	PU

More news

Quotes 5-day view

Date	Price	Change
13/05/24	0.5	+4.17%
10/05/24	0.48	-12.73%
09/05/24	0.55	+7.84%
08/05/24	0.51	-3.77%
07/05/24	0.53	-1.85%

Delayed Quote Deutsche Boerse AG

Last update May 13, 2024 at 07:01 pm

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	UCB
Issuer	Société Générale
WKN	SR8V4E
ISIN	DE000SR8V4E1
Date issued	28/05/2020
Strike	82.97 €
Maturity	Unlimited
Parity	1 : 1
Emission price	10.11 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	10.35 €
Lowest since issue	0.46 €
Spread	0.01 €
Spread %	1.96%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

123 EUR

Average target price

125.5 EUR

Spread / Average Target

+2.03%

Consensus